These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2126146)

  • 61. Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: a randomized multicenter trial. Hepatitis Interventional Therapy Group.
    Lindsay KL; Davis GL; Schiff ER; Bodenheimer HC; Balart LA; Dienstag JL; Perrillo RP; Tamburro CH; Goff JS; Everson GT; Silva M; Katkov WN; Goodman Z; Lau JY; Maertens G; Gogate J; Sanghvi B; Albrecht J
    Hepatology; 1996 Nov; 24(5):1034-40. PubMed ID: 8903371
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Treatment of chronic delta infection with recombinant human interferon alpha 2c at high doses.
    Porres JC; Carreño V; Bartolomé J; Moreno A; Galiana F; Quiroga JA
    J Hepatol; 1989 Nov; 9(3):338-44. PubMed ID: 2691569
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Approaches to the treatment of hepatitis B virus and delta-related liver disease.
    Thomas HC; Lever AM; Scully LJ; Pignatelli M
    Semin Liver Dis; 1986 Feb; 6(1):34-41. PubMed ID: 2424091
    [No Abstract]   [Full Text] [Related]  

  • 64. An economic evaluation of the costs of alpha-interferon treatment of chronic active hepatitis due to hepatitis B or C virus.
    Garcia de Ancos JL; Roberts JA; Dusheiko GM
    J Hepatol; 1990; 11 Suppl 1():S11-8. PubMed ID: 2127784
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multi-center, randomized, double-blind, placebo-controlled trial. Leich Study Group.
    Niederau C; Strohmeyer G; Heintges T; Peter K; Göpfert E
    Hepatogastroenterology; 1998; 45(21):797-804. PubMed ID: 9684137
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Interferon treatment of chronic viral hepatitis].
    Pirovino M
    Ther Umsch; 1992 May; 49(5):302-9. PubMed ID: 1377840
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hepatitis B viral infection.
    Thomas HC
    Am J Med; 1988 Aug; 85(2A):135-40. PubMed ID: 3136648
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Treatment of chronic non-A non-B hepatitis with human interferon beta: a preliminary study.
    Kiyosawa K; Sodeyama T; Nakano Y; Yoda H; Tanaka E; Hayata T; Tsuchiya K; Yousuf M; Furuta S
    Antiviral Res; 1989 Oct; 12(3):151-61. PubMed ID: 2516430
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Therapy of chronic non-A, non-B hepatitis with interferon].
    Hess G
    Fortschr Med; 1991 Jan; 109(2):33-4, 39-40. PubMed ID: 1902813
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Alpha 2 recombinant interferon in the treatment of chronic hepatitis delta virus (HDV) hepatitis.
    Rosina F; Saracco G; Lattore V; Quartarone V; Rizzetto M; Verme G; Trinchero P; Sansalvadore F; Smedile A
    Prog Clin Biol Res; 1987; 234():299-303. PubMed ID: 3628384
    [No Abstract]   [Full Text] [Related]  

  • 71. Use of interferon in the treatment of chronic viral hepatitis.
    Gibas AL
    Gastroenterologist; 1993 Jun; 1(2):129-42. PubMed ID: 8049886
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Interferon in the management of chronic hepatitis B.
    Perrillo RP
    Dig Dis Sci; 1993 Apr; 38(4):577-93. PubMed ID: 8462360
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Treatment of chronic type C hepatitis with alpha interferon.
    Hoofnagle JH; Di Bisceglie AM
    Semin Liver Dis; 1989 Nov; 9(4):259-63. PubMed ID: 2513647
    [No Abstract]   [Full Text] [Related]  

  • 74. Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies.
    Calleja JL; Albillos A; Cacho G; Iborra J; Abreu L; Escartín P
    J Hepatol; 1996 Mar; 24(3):308-12. PubMed ID: 8778197
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Treatment of chronic hepatitis B: case selection and duration of therapy.
    Leung N
    J Gastroenterol Hepatol; 2002 Apr; 17(4):409-14. PubMed ID: 11982721
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The potential of RNA interference as a tool in the management of viral hepatitis.
    Taylor JA; Naoumov NV
    J Hepatol; 2005 Jan; 42(1):139-44. PubMed ID: 15629519
    [No Abstract]   [Full Text] [Related]  

  • 77. Treatment of chronic hepatitis D virus infection with low and high doses of interferon-alpha 2a: utility of polymerase chain reaction in monitoring antiviral response.
    Madejón A; Cotonat T; Bartolomé J; Castillo I; Carreño V
    Hepatology; 1994 Jun; 19(6):1331-6. PubMed ID: 8188163
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Recombinant alfa interferon in the treatment of chronic B and non-A, non-B hepatitis: preliminary results].
    da Silva LC; Carrilho FJ; da Fonseca LE; Farias SM; Faggion P; Granato CF; Vianna MR; Alves VA; Gayotto LC
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(5):201-6. PubMed ID: 2517713
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The A to F of viral hepatitis.
    Lancet; 1990 Nov; 336(8724):1158-60. PubMed ID: 1978030
    [No Abstract]   [Full Text] [Related]  

  • 80. A multicenter, randomized, controlled trial of interferon alfacon-1 compared with alpha-2a-interferon in Chinese patients with chronic hepatitis C virus infection.
    Yao GB; Fu XX; Tian GS; Xu DZ; Hao LJ; Huangfu YS; Su CX
    J Gastroenterol Hepatol; 2000 Oct; 15(10):1165-70. PubMed ID: 11106097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.